Versant Capital Management’s Zimmer Biomet ZBH Stock Holding History

Versant Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238K	Sell	2,763 -188	-6%	-$16.5K	0.02%	556
2026 Q1	$267K	Buy	2,951 +2,589	+715%	+$238K	0.03%	485
2025 Q4	$32.6K	Buy	362 +232	+178%	+$22K	﹤0.01%	1334
2025 Q3	$12.8K	Buy	130 +98	+306%	+$9.71K	﹤0.01%	1824
2025 Q2	$2.92K	Sell	32 -1,930	-98%	-$187K	﹤0.01%	2307
2025 Q1	$222K	Buy	1,962 +1,784	+1,002%	+$191K	0.04%	383
2024 Q4	$18.8K	Buy	178 +14	+9%	+$1.5K	﹤0.01%	1066
2024 Q3	$17.7K	Buy	164 +140	+583%	+$15.3K	﹤0.01%	845
2024 Q2	$2.6K	Sell	24 -16	-40%	-$1.89K	﹤0.01%	1437
2024 Q1	$5.28K	Hold	40	–	–	﹤0.01%	1010
2023 Q4	$4.87K	Buy	40 +16	+67%	+$1.78K	﹤0.01%	974
2023 Q3	$2.69K	Sell	24 -14	-37%	-$1.78K	﹤0.01%	1202
2023 Q2	$5.53K	Buy	38 +14	+58%	+$1.9K	﹤0.01%	1002
2023 Q1	$3.1K	Hold	24	–	–	﹤0.01%	1129
2022 Q4	$3.06K	Hold	24	–	–	﹤0.01%	1033
2022 Q3	$3K	Hold	24	–	–	﹤0.01%	1030
2022 Q2	$3K	Hold	24	–	–	﹤0.01%	1044
2022 Q1	$3K	Sell	24 -1	-4%	-$121	﹤0.01%	1082
2021 Q4	$3K	Hold	25	–	–	﹤0.01%	1079
2021 Q3	$4K	Hold	25	–	–	﹤0.01%	989
2021 Q2	$4K	Sell	25 -4	-14%	-$648	﹤0.01%	997
2021 Q1	$4K	Hold	29	–	–	﹤0.01%	1121
2020 Q4	$4K	Sell	29 -103	-78%	-$14.5K	﹤0.01%	1013
2020 Q3	$17K	Hold	132	–	–	0.01%	489
2020 Q2	$15K	Hold	132	–	–	0.01%	508
2020 Q1	$12K	Buy	132 +97	+277%	+$12.7K	0.01%	513
2019 Q4	$5K	Sell	35 -7	-17%	-$966	﹤0.01%	955
2019 Q3	$5K	Sell	42 -2	-5%	-$258	﹤0.01%	976
2019 Q2	$5K	Sell	44 -22	-33%	-$2.58K	﹤0.01%	980
2019 Q1	$8K	Hold	66	–	–	﹤0.01%	992
2018 Q4	$6K	Sell	66 -11	-14%	-$1.24K	﹤0.01%	991
2018 Q3	$9K	Sell	77 -52	-40%	-$6.18K	﹤0.01%	933
2018 Q2	$13K	Hold	129	–	–	0.01%	816
2018 Q1	$13K	Buy	129 +2	+2%	+$232	0.01%	814
2017 Q4	$14K	Buy	127 +49	+63%	+$5.54K	0.01%	801
2017 Q3	$8K	Sell	78 -10	-11%	-$1.15K	﹤0.01%	937
2017 Q2	$10K	Hold	88	–	–	0.01%	882
2017 Q1	$10K	Sell	88 -11	-11%	-$1.25K	0.01%	855
2016 Q4	$9K	Buy	99 +2	+2%	+$214	0.01%	878
2016 Q3	$12K	Buy	97 +5	+5%	+$618	0.01%	755
2016 Q2	$10K	Hold	92	–	–	0.01%	792
2016 Q1	$9K	Buy	92 +24	+35%	+$2.32K	0.01%	803
2015 Q4	$6K	Buy	+68	New	+$6.65K	﹤0.01%	903

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Versant Capital Management's ZBH Position: Q2 2026 in Review

Versant Capital Management reduced its Zimmer Biomet (ZBH) stake by 6.4% in Q2 2026, selling an estimated $16.5K and leaving 2,763 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #556.

Versant Capital Management first reported a position in ZBH in Q4 2015 and has held it in 43 quarters since. The position peaked at $267K in Q1 2026. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Versant Capital Management held 2,763 shares of Zimmer Biomet worth $238K as of Q2 2026.
Versant Capital Management sold 188 Zimmer Biomet shares in Q2 2026, an estimated $16.5K.
Zimmer Biomet made up 0.02% of Versant Capital Management's portfolio in Q2 2026, its #556 holding.
Versant Capital Management first reported a position in Zimmer Biomet in Q4 2015 and has held it in 43 quarters since.
Versant Capital Management's Zimmer Biomet position peaked at $267K in Q1 2026.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.